Ultralife Corporation shares have gained 34.6% since the company reported second-quarter 2026 earnings, outperforming the S&P 500 Index's 0.04% loss over the same period. The company posted revenues of $47.9 million, down 1.3% from $48.6 million a year earlier, while GAAP earnings per share increased to $0.15 from $0.05. Gross margin expanded 500 basis points to 28.9%, helped by a $1.1 million net refund of previously paid IEEPA tariffs, and backlog reached a company record of $117.5 million. Management did not provide specific guidance but maintained an outlook for profitable growth in 2026, supported by backlog execution and margin initiatives.
Ultralife CorporationQ2 earnings beat with EPS up and gross margin expansion, despite revenue dip.
